首页|非离子型碘对比剂的临床合理应用及管理对策

非离子型碘对比剂的临床合理应用及管理对策

扫码查看
目的 分析不同浓度、注射速率的非离子型碘对比剂成像效果及不良反应,为临床CT检查中正确选择用药、扫描方案及不良反应处理提供依据。方法 随机选择12 500 例使用非离子型碘对比剂患者,根据常用的三种对比剂使用模式,将患者分为A(2 780例)、B(6 230例)、C(3 490例)组。A组采用碘帕醇370 mg/L,速率5 mL/s;B组采用碘海醇300 mg/L,速率3 mL/s;C组采用碘克沙醇270 mg/L,速率2。5 mL/s。比较三组的影像图像质量、对比剂渗漏及不良反应发生情况。结果 三组患者的图像质量不合格 153 例,占比 1。22%(153/12 500);图像质量合格 12 347 例,占比98。78%(12 347/12 500)。三组患者的图像质量合格率比较,差异无统计学意义(P>0。05)。三组患者对比剂渗漏25例,发生率为0。20%(25/12 500);A组对比剂渗漏17例,发生率为 0。61%(17/2 780);B组对比剂渗漏 7 例,发生率为 0。11%(7/6 230);C组对比剂渗漏 1 例,发生率为0。03%(1/3 490);三组患者的对比剂渗漏发生率比较,差异具有统计学意义(P<0。005)。三组患者共发生不良反应97 例,占比0。78%(97/12 500),其中轻度反应 84 例,占比 0。67%(84/12 500);中度反应13 例,占比0。10%(13/12 500);无重度不良反应。三组患者的不良反应总发生率比较,差异具有统计学意义(P<0。005);B组的不良反应总发生率低于A组,差异具有统计学意义(P<0。05)。结论 预防和处理非离子型碘对比剂的应用风险是目前CT扫描中一个十分重要的问题;从非离子型碘对比剂不良反应风险预防、对比剂渗漏风险预防与护理等方面加以分析,可在确保获得最佳图像效果的同时保证患者安全。
Clinical rational application and management countermeasures of non-ionic iodine contrast agent
Objective To analyze the imaging effects and adverse reactions of non-ionic iodine contrast agent with different concentrations and injection rates in CT examination,and provide basis for the correct selection of drugs,scanning schemes and adverse reactions in clinical CT examination.Methods A total of 12 500 patients with non-ionic iodine contrast agent were randomly selected.According to the three commonly used contrast agent use patterns,the patients were divided into group A(2 780 cases),group B(6 230 cases)and group C(3 490 cases).The group A was treated with iopamidol 370 mg/L at a rate of 5 mL/s;the group B was treated with iohexol 300 mg/L at a rate of 3 mL/s;the group C was treated with iodixanol 270 mg/L at a rate of 2.5 mL/s.The image quality,contrast agent leakage and adverse reactions of the three groups were compared.Results The image quality of the three groups of patients was unqualified in 153 cases,accounting for 1.22%(153/12 500);the image quality was qualified in 12 347 cases,accounting for 98.78%(12 347/12 500).There was no significant difference in the qualified rate of image quality among the three groups(P>0.05).There were 25 cases of contrast agent leakage in the three groups,with an incidence of 0.20%(25/12 500).There were 17 cases of contrast agent leakage in the group A,with an incidence of 0.61%(17/2 780);there were 7 cases of contrast agent leakage in the group B,and the incidence rate was 0.11%(7/6 230);there was 1 case of contrast agent leakage in the group C,and the incidence rate was 0.03%(1/3 490);there was a statistically significant difference in the incidence of contrast agent leakage among the three groups(P<0.005).There were 97 cases of adverse reactions in the three groups,accounting for 0.78%(97/12 500),including 84 cases of mild reactions,accounting for 0.67%(84/12 500);13 cases of moderate reactions,accounting for 0.10%(13/12 500);and no severe adverse reactions.The total incidence of adverse reactions in the three groups was statistically significant(P<0.005);the total incidence of adverse reactions in the group B was lower than that in the group A,and the difference was statistically significant(P<0.05).Conclusion Prevention and treatment of the application risk of non-ionic iodine contrast agent is a very important issue in CT scan.Analysis from the aspects of risk prevention of adverse reactions of non-ionic iodine contrast agent,risk prevention and nursing of contrast agent leakage can ensure the safety of patients while ensuring the best image effect.

non-ionic iodine contrast agentCT imaging technologycontrast agent leakage

胡承涛、淳彩雯

展开 >

伊犁州新华医院,新疆 伊宁,835000

非离子型碘对比剂 CT成像技术 对比剂渗漏

伊犁哈萨克自治州科技计划项目

YZ2020YD010

2024

临床医学研究与实践

临床医学研究与实践

ISSN:
年,卷(期):2024.9(7)
  • 19